| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $95.6M | 0.13% | 1.53M | −5.5% | Q2 2026 |
| Bridgewater Associates · Ray Dalio | $1.2M | 0.00% | 18.42K | New | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CRVL trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 13, 2026 | Corstar Holdings IncBeneficial Owner of more than 10% of a Class of Security | Sale at price 69.05 - 70.16 per share. | 158.7K | $11.10M |
| Sep 3, 2026 | Corstar Holdings IncBeneficial Owner of more than 10% of a Class of Security | Sale at price 68.76 - 68.91 per share. | 66.3K | $4.56M |
| Aug 31, 2026 | Jessup R JuddDirector | Sale at price 70.07 per share. | 4K | $281.89K |
| Aug 26, 2026 | Jessup R JuddDirector | Sale at price 70.64 - 70.71 per share. | 2.8K | $199.60K |
| Aug 19, 2026 | Yoss Jennifer LOfficer | Sale at price 70.92 per share. | 2.1K | $148.92K |
| Aug 19, 2026 | Yoss Jennifer LOfficer | Conversion of Exercise of derivative security at price 65.72 per share. | 2.1K | $138.01K |
| Aug 3, 2026 | Nichols Brian SChief Financial Officer | Conversion of Exercise of derivative security at price 52.65 per share. | 51 | $2.69K |
| Jul 30, 2026 | Hoops Alan RDirector | Conversion of Exercise of derivative security at price 14.44 per share. | 9K | $129.96K |
| Jul 28, 2026 | Bertels Mark EOfficer | Conversion of Exercise of derivative security at price 52.65 per share. | 750 | $39.48K |
| Jun 11, 2026 | Combs Michael GChief Executive Officer | Sale at price 60.79 per share. | 500 | $30.39K |
| Jun 11, 2026 | Shishin MaximChief Technology Officer | Sale at price 60.59 per share. | 2.3K | $136.33K |
| Jun 11, 2026 | Shishin MaximChief Technology Officer | Conversion of Exercise of derivative security at price 52.65 per share. | 2.3K | $118.46K |
| Jun 10, 2026 | Jessup R JuddDirector | Conversion of Exercise of derivative security at price 14.44 per share. | 9K | $129.96K |
| Jun 10, 2026 | Combs Michael GChief Executive Officer | Sale at price 60.55 - 61.38 per share. | 21K | $1.28M |
| Jun 8, 2026 | Michael Jeffrey JDirector and Beneficial Owner of more than 10% of a Class of Security | Sale at price 60.98 per share. | 9K | $548.83K |
| Jun 8, 2026 | Michael Jeffrey JDirector and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 14.44 per share. | 9K | $129.96K |
| Jun 7, 2026 | Combs Michael GChief Executive Officer | Sale at price 60.22 per share. | 7K | $421.56K |
| May 25, 2026 | Yoss Jennifer LOfficer | Sale at price 61.02 per share. | 2K | $121.98K |
| May 25, 2026 | Yoss Jennifer LOfficer | Conversion of Exercise of derivative security at price 49.63 - 52.00 per share. | 2K | $101.81K |
| Apr 30, 2026 | Nichols Brian SChief Financial Officer | Conversion of Exercise of derivative security at price 39.83 per share. | 18 | $717 |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.9 | -25.9 | 6.0 | 5.1 | 7.5 | 1.2 | -3.9 | 14.7 | 8.2 | 4.7 | +15.3% | ||
| 2025 | 4.1 | -4.8 | 1.5 | -2.9 | 2.3 | -7.6 | -13.8 | 0.5 | -13.1 | -4.5 | -1.0 | -7.5 | −39.2% |
| 2024 | -4.8 | 3.7 | 7.8 | -9.2 | 0.4 | 6.0 | 20.7 | 4.5 | 1.9 | -8.9 | 22.7 | -8.7 | +35.0% |
| 2023 | 22.6 | 1.2 | 5.5 | 6.2 | -3.3 | -1.0 | 5.7 | 5.8 | -9.1 | -1.4 | 7.7 | 18.4 | +70.1% |
| 2022 | -15.3 | -9.7 | 5.9 | -7.9 | -3.8 | -1.3 | 12.0 | -5.8 | -10.9 | 18.6 | -6.8 | -5.0 | −30.1% |
| 2021 | -6.8 | 2.7 | 1.1 | 14.1 | 6.5 | 7.8 | 4.9 | 17.0 | 13.0 | -1.6 | 2.6 | 10.6 | +96.2% |
| 2020 | 4.8 | -24.7 | -20.9 | -3.3 | 28.8 | 4.4 | 12.1 | 4.4 | 2.9 | 6.8 | -1.8 | 18.4 | +21.3% |
| 2019 | 1.2 | 7.7 | -3.1 | 10.1 | 3.0 | 17.6 | -2.1 | -1.1 | -10.1 | 4.5 | 4.3 | 5.9 | +41.5% |
| 2018 | -2.4 | -5.2 | 3.3 | -3.0 | 3.0 | 6.9 | 6.2 | 3.7 | 1.3 | -3.8 | 20.3 | -11.4 | +16.7% |
| 2017 | 4.8 | 5.3 | 7.7 | 2.3 | 4.7 | 1.8 | 0.2 | 9.1 | 4.8 | 10.3 | -7.9 | -4.3 | +44.5% |
| 2016 | 3.9 | -9.1 | -5.0 | 14.7 | 6.5 | -10.3 | 4.7 | -15.0 | -0.1 | -10.0 | -6.8 | 13.7 | −16.7% |
| 2015 | -11.5 | 7.6 | -2.9 | 3.9 | 0.4 | -10.8 | -0.2 | -6.0 | 7.6 | 2.8 | 16.7 | 13.3 | +18.0% |
| 2014 | 1.4 | -2.9 | 8.2 | -8.5 | 3.7 | -4.3 | -10.8 | 1.5 | -16.7 | 1.1 | 0.7 | 7.4 | −20.3% |
| 2013 | 2.2 | 4.9 | 3.0 | -4.1 | 9.4 | 12.7 | 15.8 | -2.8 | 12.2 | 12.5 | 11.3 | 0.9 | +108.3% |
| 2012 | -5.9 | -6.9 | -12.0 | 9.0 | 2.2 | 10.3 | -5.8 | -5.1 | 2.2 | -5.0 | -1.4 | 6.9 | −13.3% |
| 2011 | 4.4 | -1.9 | 7.4 | -2.6 | 2.2 | -11.4 | -1.6 | -1.1 | -6.8 | 21.3 | -7.5 | 8.4 | +6.9% |
| 2010 | -10.1 | 6.8 | 11.0 | -6.9 | 6.5 | -4.7 | 17.8 | -7.6 | 15.4 | 5.5 | 2.0 | 5.8 | +44.2% |
| 2009 | -19.7 | 6.9 | 7.2 | 11.3 | -4.7 | 6.2 | 7.2 | 23.1 | -5.5 | 0.4 | 4.9 | 12.2 | +52.6% |
| 2008 | 7.5 | 21.7 | 1.5 | 7.6 | 9.5 | -5.9 | -3.3 | -11.1 | -1.7 | -6.3 | -17.6 | -0.5 | −4.5% |
| 2007 | -0.9 | -36.1 | 0.4 | -10.1 | 0.9 | -4.7 | 1.8 | -5.8 | -7.8 | 15.0 | -12.5 | -1.0 | −51.6% |
No analyst coverage for this instrument.
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.